<?xml version="1.0" encoding="UTF-8"?>
<p id="p0115">Given the past experiences outlined above and the current threat of SARS-CoV-2, experts have proposed the potential clinical benefit of convalescent plasma in the management of COVID-19 infected patients [
 <xref rid="bb0005" ref-type="bibr">1</xref>,
 <xref rid="bb0015" ref-type="bibr">3</xref>,
 <xref rid="bb0035" ref-type="bibr">7</xref>,
 <xref rid="bb0150" ref-type="bibr">30</xref>,
 <xref rid="bb0220" ref-type="bibr">44</xref>]. To date though, only three case series of convalescent plasma in the setting of COVID-19 has been published from January to April of 2020 (See 
 <xref rid="t0005" ref-type="table">Table 1</xref> for summary of reports) [
 <xref rid="bb0225" ref-type="bibr">[45]</xref>, 
 <xref rid="bb0230" ref-type="bibr">[46]</xref>, 
 <xref rid="bb0235" ref-type="bibr">[47]</xref>].
</p>
